Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Goal: Selectively clear senescent cells by disrupting the nuclear FOXO4p53 interaction so freed p53 triggers apoptosis demonstrated in preclinical (mouse) work only, not established in humans [1] [2] Schedule: Daily subcutaneous injections across a 16-week course with gradual dose escalation
The proportion of patients receiving B12 injections at the correct frequency also increased by 14% (58% to 72%), which resulted in fewer patients receiving unnecessary injections
Allergic Reactions: When the body becomes hypersensitive to the compound, it triggers an immune response, resulting in itching, swelling, and hives
Five-times-weekly dosing (weekdays on, weekends off) reduces total usage by about 30% while maintaining most benefits
Other signs may include jaundice, swelling, and changes in mental status in severe cases
